327 related articles for article (PubMed ID: 34884632)
21. Intratumoral Injection of Low-Energy Photon-Emitting Gold Nanoparticles: A Microdosimetric Monte Carlo-Based Model.
Laprise-Pelletier M; Ma Y; Lagueux J; Côté MF; Beaulieu L; Fortin MA
ACS Nano; 2018 Mar; 12(3):2482-2497. PubMed ID: 29498821
[TBL] [Abstract][Full Text] [Related]
22. Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability.
Stepanenko AA; Dmitrenko VV
Gene; 2015 Dec; 574(2):193-203. PubMed ID: 26260013
[TBL] [Abstract][Full Text] [Related]
23. The noncellular reduction of MTT tetrazolium salt by TiO₂ nanoparticles and its implications for cytotoxicity assays.
Lupu AR; Popescu T
Toxicol In Vitro; 2013 Aug; 27(5):1445-50. PubMed ID: 23531555
[TBL] [Abstract][Full Text] [Related]
24. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
[TBL] [Abstract][Full Text] [Related]
25. Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.
Mangadlao JD; Wang X; McCleese C; Escamilla M; Ramamurthy G; Wang Z; Govande M; Basilion JP; Burda C
ACS Nano; 2018 Apr; 12(4):3714-3725. PubMed ID: 29641905
[TBL] [Abstract][Full Text] [Related]
26. Multimodal cancer cell therapy using Au@Fe
Hosseini V; Mirrahimi M; Shakeri-Zadeh A; Koosha F; Ghalandari B; Maleki S; Komeili A; Kamrava SK
Photodiagnosis Photodyn Ther; 2018 Dec; 24():129-135. PubMed ID: 30077650
[TBL] [Abstract][Full Text] [Related]
27. Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining.
Masarik M; Gumulec J; Hlavna M; Sztalmachova M; Babula P; Raudenska M; Pavkova-Goldbergova M; Cernei N; Sochor J; Zitka O; Ruttkay-Nedecky B; Krizkova S; Adam V; Kizek R
Integr Biol (Camb); 2012 Jun; 4(6):672-84. PubMed ID: 22592803
[TBL] [Abstract][Full Text] [Related]
28. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
29. The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival.
Sieuwerts AM; Klijn JG; Peters HA; Foekens JA
Eur J Clin Chem Clin Biochem; 1995 Nov; 33(11):813-23. PubMed ID: 8620058
[TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of electroporated gold nanoparticles and extremely-low frequency electromagnetic field anticancer activity against Hep-2 laryngeal cancer cells.
Alshehri MA; Wierzbicki PM; Kaboo HF; Nasr MSM; Amer ME; Abuamara TMM; Badr DA; Saleh KA; Fazary AE; Mohamed AF
Folia Histochem Cytobiol; 2019; 57(4):159-167. PubMed ID: 31746453
[TBL] [Abstract][Full Text] [Related]
31. Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability.
Sylvester PW
Methods Mol Biol; 2011; 716():157-68. PubMed ID: 21318905
[TBL] [Abstract][Full Text] [Related]
32. The systematic evaluation of size-dependent toxicity and multi-time biodistribution of gold nanoparticles.
Li X; Hu Z; Ma J; Wang X; Zhang Y; Wang W; Yuan Z
Colloids Surf B Biointerfaces; 2018 Jul; 167():260-266. PubMed ID: 29677597
[TBL] [Abstract][Full Text] [Related]
33. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity.
Twentyman PR; Luscombe M
Br J Cancer; 1987 Sep; 56(3):279-85. PubMed ID: 3663476
[TBL] [Abstract][Full Text] [Related]
34. Cellular uptake behaviour, photothermal therapy performance, and cytotoxicity of gold nanorods with various coatings.
Zhu XM; Fang C; Jia H; Huang Y; Cheng CH; Ko CH; Chen Z; Wang J; Wang YX
Nanoscale; 2014 Oct; 6(19):11462-72. PubMed ID: 25155843
[TBL] [Abstract][Full Text] [Related]
35. Biocorona formation on gold nanoparticles modulates human proximal tubule kidney cell uptake, cytotoxicity and gene expression.
Ortega MT; Riviere JE; Choi K; Monteiro-Riviere NA
Toxicol In Vitro; 2017 Aug; 42():150-160. PubMed ID: 28433809
[TBL] [Abstract][Full Text] [Related]
36. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles.
Liu X; Huang N; Wang H; Li H; Jin Q; Ji J
Biomaterials; 2013 Nov; 34(33):8370-81. PubMed ID: 23932246
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric Assessment of Gold Nanoparticle Cytotoxicity in Cancerous and Healthy Cells: The Role of Size, Shape, and Surface Chemistry.
Bhamidipati M; Fabris L
Bioconjug Chem; 2017 Feb; 28(2):449-460. PubMed ID: 27992181
[TBL] [Abstract][Full Text] [Related]
38. Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.
Thipe VC; Panjtan Amiri K; Bloebaum P; Raphael Karikachery A; Khoobchandani M; Katti KK; Jurisson SS; Katti KV
Int J Nanomedicine; 2019; 14():4413-4428. PubMed ID: 31417252
[No Abstract] [Full Text] [Related]
39. Biocompatibility of gold nanoparticles in retinal pigment epithelial cell line.
Karakoçak BB; Raliya R; Davis JT; Chavalmane S; Wang WN; Ravi N; Biswas P
Toxicol In Vitro; 2016 Dec; 37():61-69. PubMed ID: 27599945
[TBL] [Abstract][Full Text] [Related]
40. Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu.
Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM
Mol Pharm; 2015 Nov; 12(11):3963-72. PubMed ID: 26402157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
